{"id":5659,"date":"2015-12-09T15:51:20","date_gmt":"2015-12-09T20:51:20","guid":{"rendered":"http:\/\/localhost:10028\/practiceareas\/testosterone\/"},"modified":"2022-06-21T16:54:02","modified_gmt":"2022-06-21T20:54:02","slug":"testosteron","status":"publish","type":"practiceareas","link":"https:\/\/napolilaw.lemonadestand.org\/pl\/teren-do-cwiczen-2\/testosteron\/","title":{"rendered":"Testosterone"},"content":{"rendered":"<p>Niski poziom testosteronu, potocznie nazywany niskim t, jest jednym z najcz\u0119\u015bciej diagnozowanych schorze\u0144 w\u015br\u00f3d starzej\u0105cych si\u0119 m\u0119\u017cczyzn. Jednak opr\u00f3cz obaw, czy osoby, u kt\u00f3rych zdiagnozowano t\u0119 chorob\u0119, faktycznie na ni\u0105 cierpi\u0105 (lub po prostu do\u015bwiadczaj\u0105 normalnych objaw\u00f3w zwi\u0105zanych z wiekiem), leki wytwarzane w celu leczenia niskiego t mog\u0105 by\u0107 niebezpieczne. Je\u015bli zdiagnozowano u Ciebie niski poziom testosteronu i przepisano Ci leki o niskim st\u0119\u017ceniu,<em> lub<\/em> je\u015bli bra\u0142a\u015b zastrzyki lub tabletki z testosteronem w celu leczenia op\u00f3\u017anionego dojrzewania p\u0142ciowego, impotencji lub raka piersi, oto co musisz wiedzie\u0107:<\/p>\n<p>&nbsp;<\/p>\n<h3>Zagro\u017cenia zwi\u0105zane z lekami zawieraj\u0105cymi testosteron<\/h3>\n<p>M\u0119\u017cczyznom cz\u0119sto przepisuje si\u0119 leki o niskim st\u0119\u017ceniu w celu leczenia problem\u00f3w zwi\u0105zanych ze stylem \u017cycia, a nie problem\u00f3w medycznych. i <a href=\"http:\/\/www.wsj.com\/articles\/fda-panel-recommends-more-study-on-testosterone-drugs-for-low-t-use-1410994105\" target=\"_blank\" rel=\"noopener\">istnieje wiele zagro\u017ce\u0144 zwi\u0105zanych z przyjmowaniem lek\u00f3w o niskim t<\/a> \u2013 badania wskazuj\u0105, \u017ce przyjmowanie recepty na niski poziom testosteronu mo\u017ce zwi\u0119ksza\u0107 ryzyko wyst\u0105pienia u m\u0119\u017cczyzny:<\/p>\n<ul>\n<li>Zawa\u0142 serca;<\/li>\n<li>Udar m\u00f3zgu; I<\/li>\n<li>\u015amier\u0107.<\/li>\n<\/ul>\n<p>In fact, in March of 2015, the U.S. Food &amp; Drug Administration (FDA) issued a safety announcement cautioning against the use of low-t drugs for aging, and requiring low-t drug manufacturers to change labels on their products to include risks of heart attack and stroke.<\/p>\n<p>Testosterone injections may also be given to women who are suffering from breast cancer, or to men or boys who are suffering from symptoms caused by a lack of the hormone (delayed puberty, erectile dysfunction, etc.) However, testosterone injections, pellets, and pills have been associated with emotional changes, changes in sexual function, changes in sleep patterns, gynecomastia, and more.<\/p>\n<p>&nbsp;<\/p>\n<h3>Co musz\u0119 wiedzie\u0107 o sk\u0142adaniu pozwu?<\/h3>\n<p><a href=\"http:\/\/www.accessdata.fda.gov\/scripts\/cder\/drugsatfda\/index.cfm?fuseaction=Search.SearchAction&amp;SearchType=BasicSearch&amp;searchTerm=testosterone&amp;Search_Button=Submit\" target=\"_blank\" rel=\"noopener\">Leki o niskim t i terapia testosteronem<\/a> can be very dangerous for a patient. If you have suffered harm as a result of either, you may have the right to civil action. To help you understand whether or not you are entitled to file a suit and reclaim damages, and how to file a lawsuit directly against a dangerous drug\u2019s manufacturer, you need an attorney.<\/p>\n<p>At Napoli Shkolnik, PLLC, our experienced <a href=\"\/pl\/teren-do-cwiczen-2\/spory-farmaceutyczne\/\">spory farmaceutyczne<\/a> zesp\u00f3\u0142 jest gotowy, aby przej\u015b\u0107 do bat dla ciebie. Aby dowiedzie\u0107 si\u0119 wi\u0119cej, um\u00f3w si\u0119 z nami na konsultacj\u0119 w celu om\u00f3wienia Twojej sprawy ju\u017c dzi\u015b.<\/p>","protected":false},"excerpt":{"rendered":"<p>Low testosterone, colloquially called low-t, is one of the most commonly diagnosed medical conditions amongst aging men. However, in addition to concerns about whether those who are diagnosed with the&#8230;<\/p>","protected":false},"featured_media":0,"menu_order":194,"template":"","practiceareas_category":[743],"class_list":["post-5659","practiceareas","type-practiceareas","status-publish","hentry","practiceareas_category-pharmaceutical-litigation"],"acf":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/practiceareas\/5659","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/practiceareas"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/types\/practiceareas"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/practiceareas\/5659\/revisions"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/media?parent=5659"}],"wp:term":[{"taxonomy":"practiceareas_category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/practiceareas_category?post=5659"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}